MOH — Molina Healthcare, Inc.
NYSE
Q2 2026 Earnings Call Summary
July 23, 2026
Molina Healthcare Q2 2026 Earnings Call Summary
1. Key Financial Results and Metrics
- Adjusted Earnings Per Share (EPS): $1.51
- Premium Revenue: $10.2 billion
- Consolidated Medical Care Ratio (MCR): 92.2%
- Adjusted Pretax Margin: 1% for the quarter, 1.3% year-to-date
- Medicaid MCR: 92.7%, in line with expectations; projected full-year MCR unchanged at 92.9%
- Medicare MCR: 90.7%, better than expected; full-year guidance improved to 92.2%
- Marketplace MCR: 88.9%, higher than expectations due to prior year items and unfavorable member acuity mix; full-year guidance revised to 90%
- Full-Year Premium Revenue Guidance: Approximately $42 billion, unchanged
- Revised Full-Year Adjusted EPS Guidance: Increased by $0.25 to at least $5.25
2. Strategic Updates and Business Highlights
- Medicaid and Medicare Growth: Strong performance in Medicaid and duals Medicare products; duals expected to contribute $1.25 per share.
- RFP Wins: Retained significant contracts in Illinois and Wisconsin, enhancing the duals business.
- M&A Activity: Active acquisition pipeline; looking for accretive opportunities in a challenging environment.
- Operational Efficiency: Continued focus on cost management with G&A ratio at 6.5%.
3. Forward Guidance and Outlook
- 2026 Guidance: EPS expected to be at least $5.25, with Medicaid margins projected to improve in 2027.
- 2027 Premium Revenue Outlook: Approximately $46.5 billion, reflecting an 11% year-over-year growth.
- EPS Building Blocks for 2027: Expected to exceed $10 per share, driven by embedded earnings and operational leverage.
- Long-Term Targets: Confident in achieving $64 billion in premium revenue by 2029.
4. Bad News, Challenges, or Points of Concern
- Marketplace Losses: Significant reduction in marketplace guidance from a gain of $0.75 to a loss of $0.75 due to prior year items and unfavorable member acuity mix.
- Regulatory Headwinds: Anticipated declines in Medicaid membership due to work requirements and other regulatory changes, potentially impacting future revenue.
- Acquisition Risks: The political and regulatory landscape may pose challenges in securing favorable rates and maintaining margins.
- Member Acuity Issues: High-cost members retained without adequate risk adjustment, leading to increased medical expenses.
5. Notable Q&A Insights
- Marketplace Dynamics: The acuity shift in the marketplace was underestimated, leading to higher costs without corresponding risk adjustment.
- Medicaid Rate Updates: Minimal off-cycle rate increases observed; guidance remains stable at 4% for the year.
- Regulatory Impacts: States are expected to adapt to new Medicaid regulations, which may lead to gradual membership declines but manageable acuity shifts.
- Cash Flow Management: Operating cash flow is less relevant; focus remains on dividend extraction from subsidiaries to support growth initiatives.
This summary encapsulates Molina Healthcare's financial performance, strategic initiatives, and outlook while highlighting challenges and insights from the Q&A session.
